Chloroquine for Treatment of Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Glioblastoma Multiforme
Related studies linked through entity extraction aliases.
Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Study of the Photon Radiosurgery System
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
- Status
- UNKNOWN
- Phase
- PHASE2
Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
GW572016 to Treat Recurrent Malignant Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)
- Status
- COMPLETED
- Phase
- PHASE2
IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
- Status
- RECRUITING
- Phase
- N/A
Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
- Status
- WITHDRAWN
- Phase
- PHASE3
The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE3
Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
- Status
- TERMINATED
- Phase
- PHASE2
Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2